Mechanism of action: Tocainide ballicule
What it isOral class IB antiarrhythmic, a lidocaine analogue; withdrawn.
Why this oneIt offered oral lidocaine-like activity for ventricular arrhythmia.
What limits itAgranulocytosis and pulmonary fibrosis ended its use.
Molecular structure: Tocainide
FDA-approved for
- ventricular arrhythmias (withdrawn) (1984)
⚠ BOXED WARNINGS
- Agranulocytosis
- Pulmonary fibrosis
Classes and tags
Clinical profile
Therapeutic safety burden4 / 4
Overdose danger3 / 4
Direct muscarinic antagonism0 / 4
Defining liabilityPotentially fatal marrow and pulmonary toxicity
Open Tocainide in the interactive console ↗